StockDuty ← Dashboard Nov 10, 2026 01:42 AM ET
SignalEU/UK

SOPHiA GENETICS SA (SOPH) Presents at 2026 UBS Global Healthcare Conference Transcript

High-priority alert based on source significance and keyword relevance.

What happened: SOPHiA GENETICS co-founder Jurgi Camblong, now Executive Chairman, discussed the company's strategy, commercial adoption and business model at the 2026 UBS Global Healthcare Conference, in a session with UBS analyst Douglas Schenkel. Why it matters: Camblong described the founding view that in precision medicine the value would lie in the data itself rather than just data production, and the session covered the company's work with hospitals, labs and biopharma companies.
SOPHiA GENETICS co-founder Jurgi Camblong, now Executive Chairman, discussed the company's strategy, commercial adoption and business model at the 2026 UBS Global Healthcare Conference, in a session with UBS analyst Douglas Schenkel.
Camblong described the founding view that in precision medicine the value would lie in the data itself rather than just data production, and the session covered the company's work with hospitals, labs and biopharma companies.
Sources